May, 2014. Montreux Capital Management, the Swiss based Asset Manager and advisor to the Montreux Care Home Fund, have joined forces with Salus Healthcare in a joint venture which combines their substantial resources, experience and industry expertise as part of both groups continuing expansion and success.

Chris Pooley, Salus Healthcare’s Investment Director comments; “The UK healthcare industry has experienced some significant changes over the past few years. As in all periods of significant change, the weak leave the industry, whilst the strong consolidate and adapt.”

Salus Healthcare, the UK healthcare and property specialist, has accumulated key assets in the North of England and strengthened the team with the industries’ best with a particular focus on the highly lucrative Learning Disabilities quadrant while Montreux have driven the expansion and continuing development of the successful Montreux Care Home Fund.

The Montreux Care Home Fund, a Luxembourg based investment strategy with award winning investment management expertise combines well with Salus’ deepened access to the finest healthcare projects and committed relationships with highly experienced property and healthcare sector practitioners. Salus and Montreux look forward to a bright future with clear vision and a pipeline of superb projects already in the works.

Oliver Harris, Managing Partner of Montreux Capital Management adds; “The Healthcare Sector in the UK is a continually flourishing quadrant. The fact the market is continuing to grow while still having relatively few participants due to the high barriers of entry mean there are huge opportunities for consolidation. Partnerships such as this exemplify the sheer scope and the lucrative prospects that the Care Home market has to offer for investors.”

Find Us

Thameside House
Hurst Road
East Molesey
KT8 9AY

T: + 44 (0) 1932 860 140
E: info@montreuxcm.com

Information on this webpage relates to and is provided by Montreux Capital Management (UK) Limited

The content of this webpage should not be construed as financial advice. Any decision to invest should be made only on the basis of the relevant documentation for each investment. Past performance is not necessarily a guide to future performance. The value of an investment may go down as well as up and investors may not get back the full amount invested. Investments in small unquoted companies carry an above-average level of risk. These investments are highly illiquid and as such, there may not be a readily available market to sell such an investment. Montreux Capital Management (UK) Limited and Sapia Partners LLP (together “the Sponsors,” or “Sponsor”) do not provide specific individual advice on the suitability of investments with regard to a potential investor’s individual circumstances, risk tolerance or investment objectives and investors should seek independent financial advice if they are in any doubt whether a product is suitable for them.

Montreux Capital Management (UK) Limited is an Appointed Representative of Sapia Partners LLP which is authorised and regulated by the Financial Conduct Authority.

ACCEPT